2014
DOI: 10.4236/alc.2014.33008
|View full text |Cite
|
Sign up to set email alerts
|

Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

Abstract: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 56 publications
0
0
0
Order By: Relevance